| 6530 |
Centers for Disease Control and Prevention |
Html |
en |
Notifiable Diseases and Mortality Tables - January 6, 2012 / 60(51);1748-1761 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| provisional 4-week totals | 0.635803 |
| Mortality Tables | 0.48809 |
| equine encephalitis virus | 0.558041 |
| Mortality Weekly Report | 0.486702 |
| Viral hemorrhagic fever¶¶¶ | 0.478562 |
| provisional cases | 0.59396 |
| Hantavirus pulmonary syndrome§ | 0.481432 |
| Staphylococcus aureus§ | 0.480571 |
| New York City | 0.472397 |
| acute hepatitis | 0.499779 |
| 2011-12 influenza season | 0.485443 |
| Cum | 0.478135 |
| noncholera Vibrio species | 0.479573 |
| influenza A virus | 0.486854 |
| National Center | 0.542789 |
| CDC Home CDC | 0.490364 |
| Hemolytic uremic syndrome | 0.482062 |
| California serogroup virus | 0.499329 |
| meningococcal disease | 0.52074 |
| historical data | 0.52138 |
| Influenza Division | 0.476529 |
| Ñ?ЛП
Notifiable Diseases | 0.515214 |
| Cumulative year-to-date counts | 0.476792 |
| 2009 pandemic | 0.506521 |
|
| Respiratory Diseases | 0.473924 |
| NN | 0.99884 |
| United States | 0.726534 |
| Vancomycin-resistant Staphylococcus aureus§ | 0.477504 |
| novel influenza | 0.5234 |
| I. Provisional cases | 0.508082 |
| 5-year weekly average†| 0.492009 |
| notifiable diseases | 0.67551 |
| Vancomycin-intermediate Staphylococcus aureus§ | 0.477293 |
| Eastern equine encephalitis | 0.487614 |
| pandemic influenza | 0.50929 |
| Influenza-associated pediatric mortality§ | 0.477714 |
| viral hemorrhagic fever | 0.473245 |
| Western equine encephalitis | 0.487274 |
| Polio virus Infection | 0.480995 |
| Total case counts | 0.473343 |
| notifiable disease reports | 0.624116 |
| current 4-week total | 0.488658 |
| Vector-Borne Infectious Diseases | 0.480187 |
| Chlamydia trachomatis infection | 0.473007 |
| TABLE I. | 0.488886 |
| dengue hemorrhagic fever | 0.475115 |
| subsequent 4-week periods | 0.484019 |
| West Nile virus | 0.479331 |
|
CLICK HERE |
| 6624 |
Centers for Disease Control and Prevention |
Html |
null |
Organ Systems and the Chemicals that Affect Them - Respiratory From the Nose to the Lungs |
The respiratory system starts with the nose, nasal cavities, paranasal sinuses, nasopharynx, and larynx. It continues with a conducting segment (trachea and bronchi) that enters the lungs. transitional segment made up of respiratory bronchioles and primary, secondary, and tertiary bronchioles moves air deep into the lungs. |
|
|
CLICK HERE |
| 6956 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Preventing Chronic Disease: Volume 9, 2012:10_0262 |
In 2005, approximately 26% of Micronesian women aged 40 or older in Hawai‘i used mammography for breast cancer screening. We describe an 18-month project to increase screening participation in this population by tailoring educational materials and using a lay educator approach. |
| lay education program | 0.481428 |
| Cancer Society Hawai‘i | 0.480341 |
| cancer education materials | 0.48394 |
| lay educator cancer | 0.500431 |
| breast cancer education | 0.553741 |
| lay educators | 0.671301 |
| Micronesian languages | 0.496257 |
| ‘Imi Hale | 0.580604 |
| home countries | 0.480266 |
| cervical cancer screening | 0.633961 |
| female Micronesian patients | 0.498465 |
| Micronesian lay educators | 0.543035 |
| tactile breast cancer | 0.486702 |
| Micronesian community | 0.476053 |
| Micronesian women | 0.827389 |
| Reduce Cancer Health | 0.501424 |
| lay education project | 0.487546 |
| breast cancer survivors | 0.48137 |
| breast cancer prevalence | 0.498704 |
| group breast cancer | 0.492782 |
| breast cancer awareness | 0.492562 |
| lay educator approach | 0.539069 |
| educators accompanied women | 0.477698 |
| Hale-Native Hawaiian Cancer | 0.476645 |
| Papa Ola Lokahi | 0.484211 |
|
| cancer awareness program | 0.480272 |
| cancer screening | 0.713037 |
| United States | 0.544608 |
| Micronesian communities | 0.494402 |
| late-stage breast cancer | 0.481113 |
| back-to-back mammogram appointments | 0.485037 |
| breast cancer screenings | 0.493003 |
| lay educator | 0.578026 |
| lay cancer education | 0.497883 |
| educational materials | 0.491053 |
| Cancer Health Disparities | 0.504507 |
| mammography screening | 0.479293 |
| National Cancer Institute | 0.496542 |
| Micronesian culture | 0.477795 |
| health care | 0.511611 |
| health care resources | 0.479116 |
| breast cancer screening | 0.702057 |
| cancer screening programs | 0.493323 |
| group in-language cancer | 0.484708 |
| breast cancer | 0.905684 |
| community-based participatory research | 0.475949 |
| lay educator model | 0.481288 |
| Hawaiian Cancer Network | 0.511691 |
| focus group | 0.478017 |
|
CLICK HERE |
| 7642 |
Centers for Disease Control and Prevention |
Html |
en |
Antiviral Drugs for Seasonal Flu: Additional Links and Resources |
Antiviral Drugs for Seasonal Influenza: Additional Links and Resources - CDC |
| influenza | 0.965766 |
| weekly FluView report | 0.409196 |
| peramivir-resistant influenza viruses | 0.959376 |
| American Academy | 0.244437 |
| United States | 0.223542 |
| age group | 0.232642 |
| influenza-related complications | 0.249776 |
| influenza A viruses | 0.607165 |
| trade name Relenza® | 0.230738 |
| latest information | 0.224279 |
| progressive illness | 0.247724 |
| oral oseltamivir | 0.418164 |
| antiviral drug | 0.327013 |
| respiratory disease | 0.233487 |
| influenza B viruses | 0.606412 |
| FDA-approved indications | 0.339673 |
| virus strains | 0.59813 |
| trade  name Rapivab® | 0.225693 |
|
| Antiviral Treatment Recommendations | 0.620876 |
| virus infections | 0.245911 |
| trade name Tamiflu® | 0.243377 |
| sporadic cases | 0.285596 |
| greater risk | 0.252455 |
| routine surveillance | 0.219088 |
| people | 0.344753 |
| inhibitor antiviral medications—oseltamivir | 0.652435 |
| virus infection | 0.244318 |
| antiviral treatment | 0.828997 |
| neuraminidase inhibitor | 0.55117 |
| H1N1 virus strains | 0.475318 |
| drug products | 0.214398 |
| Generic oseltamivir | 0.444467 |
| widespread adamantane resistance | 0.418743 |
| package inserts | 0.221877 |
| limited data | 0.241335 |
| label updates | 0.221855 |
|
CLICK HERE |
| 10022 |
Centers for Disease Control and Prevention |
Html |
en |
Text Messaging Guidelines & Best Practices |
Basic information from CDC about breast cancer. |
| American adults | 0.26616 |
| CDC’s National | 0.262728 |
| phone numbers | 0.293087 |
| opt-out message | 0.325033 |
| common abbreviations | 0.264358 |
| Disease Control | 0.266724 |
| social media tools | 0.312645 |
| Information System Security | 0.263642 |
| traditional Web sites | 0.299216 |
| communications science clearance | 0.316712 |
| compelling text messages | 0.372572 |
| program resources | 0.26324 |
| Text Messaging Projects | 0.407294 |
| Chief Information Officer | 0.308293 |
| Wireless Association | 0.266201 |
| entire message | 0.269559 |
| interesting text messages | 0.350171 |
| opt-out instructions | 0.371799 |
| text messages | 0.795253 |
| New Text Messaging | 0.486236 |
| text message | 0.37463 |
| health communication activities | 0.322257 |
| mobile phone | 0.311715 |
| health communications campaign | 0.315485 |
|
| text messaging project | 0.926827 |
| Text messaging systems | 0.400517 |
| large portion | 0.26248 |
| Digital Media Branch | 0.30994 |
| occasional text messages | 0.368247 |
| general population | 0.262273 |
| text message programs | 0.367913 |
| target audience | 0.307609 |
| important health messages | 0.356914 |
| Health Communication Science | 0.322704 |
| mobile text | 0.293353 |
| health communications program | 0.328685 |
| Text messaging programs | 0.421583 |
| easy way | 0.265237 |
| text messaging service | 0.409354 |
| mobile Web site | 0.297343 |
| text messaging plan | 0.409989 |
| health communications | 0.352526 |
| CDC text | 0.299061 |
| 160-character messages | 0.293496 |
| health marketing | 0.269401 |
| EMB staff | 0.26511 |
| Contact DMB | 0.267088 |
| larger integrated health | 0.414231 |
|
CLICK HERE |
| 10188 |
Centers for Disease Control and Prevention |
Html |
en |
Radiation Emergencies | Resource Library |
Resource Library materials for the Radiation Studies Branch. Provided by the Centers for Disease Control and Prevention (CDC). |
| public health administrators | 0.779109 |
| partnership | 0.435716 |
| emergency planning | 0.568642 |
| Assesses | 0.458444 |
| gaps | 0.452303 |
| opportunities | 0.425889 |
| considerations | 0.447618 |
| radiological incident | 0.724089 |
| radiological emergencies | 0.710862 |
| educational facility planning | 0.695536 |
| Response | 0.427142 |
|
| Educational Facilities Preparedness | 0.801151 |
| initial event | 0.587489 |
| barriers | 0.445572 |
| Radiological Emergency Preparedness | 0.945232 |
| Public Health Professionals | 0.702863 |
| radiation protection | 0.611471 |
| PIOs | 0.497688 |
| public health directors | 0.764784 |
| public health | 0.815114 |
| local public information | 0.772102 |
| Legal Study | 0.576389 |
|
CLICK HERE |
| 11317 |
Centers for Disease Control and Prevention |
Html |
en |
Testing Messages and Materials |
Testing messages and materials throughout the development process is important to figure out what is most appealing, understandable, and useful to that audience. |
| shoestring budget | 0.616607 |
| background research | 0.400868 |
| health communication efforts.It | 0.575678 |
| Harvard School | 0.515734 |
| weak skills | 0.636017 |
| 11-part Toolkit | 0.394995 |
| numbers | 0.235862 |
| NIH National Cancer | 0.541092 |
| Read testing materials | 0.591982 |
| practical approach | 0.384411 |
| health literacy resource | 0.668543 |
| different testing groups | 0.569875 |
| multimedia resource | 0.388771 |
| participatory process | 0.392155 |
| weak readers | 0.464518 |
| audience | 0.322451 |
| printed formats | 0.37925 |
| Making Written Material | 0.53764 |
| Southern Center | 0.392664 |
| health communication practice | 0.588613 |
| development process | 0.416773 |
| planning | 0.253631 |
| health literacy | 0.943591 |
| health communication | 0.699279 |
| Participatory Materials Development | 0.568303 |
|
| comprehensive set | 0.379857 |
| messages | 0.26801 |
| Health Communication Programs | 0.581225 |
| Health Literacy Studies | 0.662401 |
| Centers | 0.254666 |
| Public Health | 0.509084 |
| adult literacy groups | 0.673295 |
| Message Testing | 0.406909 |
| Medicaid Services | 0.526078 |
| strategy development | 0.383138 |
| health services | 0.411557 |
| National Cancer Institute | 0.79668 |
| Material Clear | 0.503794 |
| Medicare | 0.268318 |
| health literacy issues | 0.753515 |
| topics | 0.266743 |
| average readers | 0.393376 |
| words | 0.235882 |
| literacy-related barriers | 0.379134 |
| people | 0.262536 |
| Effective | 0.253496 |
| numeracy skills | 0.413484 |
| health literacy insights | 0.717291 |
| Pink Book | 0.380509 |
|
CLICK HERE |
| 13401 |
Centers for Disease Control and Prevention |
Html |
en |
Case Study: Reducing Radon in Illinois |
Illinois passed state laws to reduce household radon exposure. |
| radon problem | 0.691229 |
| group homes | 0.334338 |
| indoor radon exposure | 0.786193 |
| licensed radon professionals | 0.738677 |
| average radon levels | 0.855173 |
| Radon monitoring | 0.630478 |
| Illinois law requires— | 0.441016 |
| Control Plan | 0.322895 |
| U.S. Environmental Protection | 0.461621 |
| radon notification | 0.639892 |
| number | 0.247838 |
| accurate picture | 0.316842 |
| Illinois Comprehensive Cancer | 0.431879 |
| radon-resistant features | 0.33967 |
| state radon program | 0.738385 |
| homeowners | 0.22222 |
| home sales | 0.317121 |
| average household radon | 0.736166 |
| goal | 0.234901 |
|
| Agency | 0.223399 |
| test | 0.219822 |
| strategies | 0.22013 |
| liter | 0.237323 |
| radon laws | 0.62614 |
| new construction | 0.319862 |
| building types | 0.327026 |
| reporting requirement | 0.323051 |
| state laws | 0.329918 |
| radon exposure | 0.946958 |
| care centers | 0.32602 |
| schools | 0.220817 |
| household radon exposure | 0.829057 |
| EPA | 0.225528 |
| buildings | 0.220012 |
| 4pCi/L | 0.223309 |
| counties | 0.223209 |
| programs | 0.219903 |
| action level | 0.339334 |
|
CLICK HERE |
| 13888 |
Centers for Disease Control and Prevention |
Html |
en |
Diabetes Among Asians and Native Hawaiians or other PacificIslanders - United States, 2011-2014 |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). Often called 'the Voice of CDC,' the MMWR series is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominately consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians. |
| New York | 0.441043 |
| risk factors | 0.939859 |
| age-adjusted prevalence | 0.345067 |
| higher prevalence | 0.214249 |
| age-adjusted diabetes prevalence | 0.691228 |
| NHPIs | 0.423176 |
| diabetes prevalence estimate | 0.428812 |
| states | 0.228948 |
| Multivariate adjusted prevalence | 0.214745 |
| diabetes prevalence | 0.787892 |
|
| sufficient data | 0.590427 |
| Diabetes Prevention Program | 0.234568 |
| higher age-adjusted prevalence | 0.250886 |
| higher diabetes prevalences | 0.265665 |
| diabetes risk factors | 0.632233 |
| diabetes | 0.889297 |
| physical inactivity | 0.252556 |
| Asians | 0.558666 |
| state-level diabetes prevalence | 0.430737 |
|
CLICK HERE |
| 14250 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| urban rodent survey | 0.741396 |
| usual laboratory assays | 0.726111 |
| Minnesota Department | 0.876946 |
| total white blood | 0.74979 |
| Human Services | 0.713942 |
| negative Gram stain | 0.771261 |
| public health investigators | 0.743899 |
| acid-fast bacilli cultures | 0.744454 |
| U.S. Department | 0.777151 |
| environmental LCMV investigation | 0.751768 |
| electronic PDF version | 0.717464 |
| Zoonotic Infectious Diseases | 0.713136 |
| lymphocytic choriomeningitis virus | 0.744939 |
| rapid influenza assay | 0.744762 |
| solid organ transplant | 0.70947 |
| integrated pest management | 0.715424 |
| transplacental vertical transmission | 0.712662 |
| Human infection | 0.71628 |
| human LCMV infection | 0.808942 |
| acute infection | 0.704613 |
| subsequent home inspection | 0.726731 |
| human immunodeficiency virus | 0.763977 |
| etiologic agent | 0.748986 |
| local housing authorities | 0.717207 |
|
| elevated white blood | 0.746537 |
| home rodent infestation | 0.75216 |
| 1Epidemic Intelligence Service | 0.715552 |
| ill family member | 0.729824 |
| original MMWR paper | 0.723424 |
| Special Pathogens Branch | 0.729562 |
| Urban Development Healthy | 0.718277 |
| commercial reference laboratory | 0.73135 |
| herpes simplex virus | 0.842798 |
| acid amplification testing | 0.747992 |
| fecal pellet testing | 0.966959 |
| acid-fast bacilli stain | 0.750724 |
| public health | 0.780053 |
| 3Career Epidemiology Field | 0.710824 |
| erythrocyte sedimentation rate | 0.736737 |
| Public health action | 0.74813 |
| white blood cell | 0.879926 |
| city housing inspector | 0.723471 |
| simplex virus meningitis | 0.752241 |
| U.S. house mice | 0.732819 |
| CSF polymerase chain | 0.778354 |
| enzyme-linked immunosorbent assay | 0.736902 |
| pediatrician’s office | 0.742854 |
| pest management services | 0.724373 |
|
CLICK HERE |